Analyst Recommendations

Oppenheimer analyst issues OUTPERFORM recommendation for ENGN on August 27, 2024 04:05PM ET. ENGN was trading at $6.53 at issue of the analyst recommendation.The overall analyst consensus :...

August 27, 2024   ENGN -0.68%

Wells Fargo analyst issues OVERWEIGHT recommendation for TMO on August 27, 2024 04:16PM ET. The previous analyst recommendation was Underweight.TMO was trading at $610.4 at issue of the...

August 27, 2024   TMO -1.24%

Wells Fargo analyst issues OVERWEIGHT recommendation for A on August 27, 2024 04:16PM ET. The previous analyst recommendation was Equal-Weight.A was trading at $141.1 at issue of the...

August 27, 2024   A -2.39%

Wells Fargo analyst issues OVERWEIGHT recommendation for AVTR on August 27, 2024 04:17PM ET. AVTR was trading at $25.61 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   AVTR -2.04%

Wells Fargo analyst issues OVERWEIGHT recommendation for MYGN on August 27, 2024 04:17PM ET. MYGN was trading at $27.5 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   MYGN -0.19%

Wells Fargo analyst issues OVERWEIGHT recommendation for EXAS on August 27, 2024 04:17PM ET. The previous analyst recommendation was Equal-Weight.EXAS was trading at $59.89 at issue of the...

August 27, 2024   EXAS 0.82%

Wells Fargo analyst issues UNDERWEIGHT recommendation for CDNA on August 27, 2024 04:19PM ET. CDNA was trading at $31.8 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   CDNA -4.57%

Wells Fargo analyst issues OVERWEIGHT recommendation for BRKR on August 27, 2024 04:18PM ET. BRKR was trading at $63.95 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   BRKR -1.57%

Wells Fargo analyst issues OVERWEIGHT recommendation for MRVI on August 27, 2024 04:18PM ET. MRVI was trading at $9.03 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   MRVI -4.71%

Wells Fargo analyst issues UNDERWEIGHT recommendation for MLAB on August 27, 2024 04:19PM ET. MLAB was trading at $140.86 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   MLAB -2.44%